<DOC>
	<DOCNO>NCT00433472</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , MRI , may help doctor learn efaproxiral work brain help plan best treatment . PURPOSE : This clinical trial use MRI evaluate effect efaproxiral brain patient recurrent progressive glioma receive treatment clinical trial NABTT-9806 .</brief_summary>
	<brief_title>MRI Evaluating Effect Efaproxiral Brain Patients With Recurrent Progressive Glioma Enrolled Clinical Trial NABTT-9806</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether efaproxiral measurable effect brain show T2 and/or T2* MRI patient recurrent progressive malignant glioma enrol NABTT-9806 . - Determine predict oxygenation change base observed T2 MRI change patient . - Determine effect drug T2 T2* MRI relaxation time normal area brain patient . - Determine baseline oxygen extraction ratio tumor patient treated drug . - Determine whether administration drug reveal new tumor- non-tumor-related abnormality T2 T2* MRI patient . OUTLINE : This open-label , multicenter , pilot study . Patients receive efaproxiral carmustine clinical trial NABTT-9806 . During one course treatment study , patient undergo MRI oxygen administration ( baseline ) , efaproxiral infusion , every 5 minute 1 hour efaproxiral carmustine treatment . Data evaluate extent intensity T2/T2* change oxygen concentration change abnormal normal brain . PROJECTED ACCRUAL : A total 15-48 patient accrue study within 12-24 month .</detailed_description>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Recurrent progressive glioma Currently enrol clinical trial NABTT9806 PATIENT CHARACTERISTICS : No severe claustrophobia No cardiac pacemaker No MRIincompatible metallic implant PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>